MAPT and Parkinson disease: To investigate this interaction, Castillo-Carranza et al. [126] isolated and then purified tau and αS from brain tissues from patients with progressive supranuclear palsy (a rare tauopathy which prevalence ranges from 1.00 to 18 per 100,000 [127]) and Parkinson’s disease (synucleinopathy), respectively.